Physician profile
Eirwen M Miller
NPI 1720303126
$27,289.61
in general payments reported to CMS, 2019-2025
18 companies · $12K in 2025
The $12K reported for 2025 was more than what 92% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,037 · 2020: $285 · 2021: $243 · 2022: $738 · 2023: $4,872 · 2024: $4,129 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $2,723 · Travel and Lodging: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,147.50 |
| Food and Beverage | $2,722.51 |
| Travel and Lodging | $1,115.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $8,602.88 | 2022-2025 | Jemperli, Zejula |
| Astrazeneca Pharmaceuticals Lp | $5,718.85 | 2019-2025 | Lynparza |
| Tesaro, INC. | $4,385.51 | 2019 | |
| Ethicon US, LLC | $3,580.58 | 2019-2025 | Ethicon, Surgicel Nu-Knit, Vistaseal |
| Medtronic, INC. | $2,856.30 | 2025 | Auto Suture, Signia |
| Genmab U.S., INC. | $483.02 | 2022-2024 | Tivdak |
| Eisai INC. | $305.46 | 2023-2025 | |
| Abbvie INC. | $268.53 | 2024-2025 | |
| Clovis Oncology, INC. | $237.68 | 2020-2022 | |
| Pfizer INC. | $149.86 | 2024 | |
| Corcept Therapeutics | $127.68 | 2025 | Korlym |
| Intuitive Surgical, INC. | $119.54 | 2023 | Da Vinci Surgical System |
| Immunogen, INC. | $118.65 | 2024 | Elahere |
| Myriad Genetic Laboratories, INC. | $108.45 | 2021 | |
| Merck Sharp & Dohme LLC | $106.46 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Medicine, INC. | $104.64 | 2019 | |
| Stryker Corporation | $15.52 | 2025 | Neptune, Photonblade |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eirwen Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.